The global Flow Cytometry Market was valued at USD 5.34 billion in 2023 and is projected to reach USD 11.41 billion by 2032, growing at a CAGR of 8.82% during the forecast period 2024–2032. This growth is fueled by rising demand for precision diagnostics, personalized medicine, and advancements in immuno-oncology, particularly in cancer and autoimmune disease research.